Skip to main content
. 2014 Mar 13;9(3):e89637. doi: 10.1371/journal.pone.0089637

Table 3. Antimicrobial resistance rates of K. pneumonia.

Antimicrobial agent Resistance rate a : % Mean resistance rate b
study reference [41] [43] [18] SHCH AHC
study period ′99–′00 ′02 –′04 ′07–′10 07–′10 07–′11
n. of isolates 25 36 47 6 9 n N %
amoxicillin 100.0 6 / 6 100.0
amoxicillin-clavulanic acid 22.2 21.3 33.3 66.0 26 / 98 26.5
imipenem 0.0 2.1 0.0 1 / 92 1.1
meropenem 0.0 0 / 6 0.0
cefalothin 4.0 1 / 25 4.0
cefuroxime 11.1 4 / 36 11.1
cefotaxim 19.2 (n = 38 tested) 100.0 18 / 56 32.2
ceftriaxone 2.8 66.7 75.0 12 / 51 23.1
ceftazidime 19.1 100.0 18 / 56 32.1
cefepime 23.6 11 / 47 23.6
cefpodoxime 86.0 8 / 9 86.0
gentamicin 0.0 17.0 16.7 63.0 15 / 87 16.9
amikacin 0.0 2.1 0.0 1 / 78 1.3
chloramphenicol 67.0 6 / 9 67.0
colistin 0.0 0 / 9 0.0
thrimetoprim/sulfamethoxazole 45.7 (n = 35 tested) 83.3 63.0 32 / 62 51.9
ciprofloxacin 0.0 18.6 16.7 50.0 14 / 98 14.5

Notes:

a

Number of resistant strains/total number of strains in each study, expressed as %.

[41] Methods and breakpoints: details not given.

[43] Methods: broth microdilution; (CLSI).

[18] Methods: disk diffusion and Etest; breakpoints (RSFM 2007).

SHCH: Methods: disk diffusion and Etest; breakpoints (CLSI 2012).

AHC: Methods: disk diffusion and Etests; breakpoints (CLSI 2011).

b

Sum of all resistant organisms/sum of all organisms tested.